Stoke Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Stoke Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Stoke Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Stoke Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $7.3M | 1.4M | 5.26 |
| 2023-09-30 | $510k | 129k | 3.94 |
| 2023-06-30 | $994k | 94k | 10.63 |
| 2023-03-31 | $685k | 82k | 8.33 |
| 2022-12-31 | $626k | 68k | 9.23 |
| 2022-06-30 | $1.6M | 122k | 13.21 |
| 2022-03-31 | $2.4M | 114k | 21.05 |
| 2021-12-31 | $3.0M | 126k | 23.99 |
| 2021-09-30 | $4.4M | 173k | 25.44 |
| 2021-03-31 | $22M | 558k | 38.84 |
| 2020-12-31 | $36M | 577k | 61.93 |
| 2020-09-30 | $3.6M | 109k | 33.49 |
| 2020-06-30 | $3.4M | 143k | 23.83 |
| 2019-12-31 | $1.9M | 68k | 28.32 |
| 2019-09-30 | $993k | 46k | 21.50 |
| 2019-06-30 | $2.3M | 80k | 29.17 |